Miglustat G.L. is indicated for the oral treatment of mild to moderate type I Gaucher disease. Miglustat G.L. may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. Miglustat G.L. is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick type C disease.